Webinars

The Gut-Joint Axis: A New Target

The Gut-Joint Axis: A New Target

Oct 11, 2021

Oct 11, 2021

Oct 11, 2021

Event Overview:

This session introduced the emerging science behind the gut–joint axis and its implications for joint health innovation. The webinar highlighted how microbiome modulation is opening new avenues for joint health interventions and claim substantiation.

Event Overview:

This session introduced the emerging science behind the gut–joint axis and its implications for joint health innovation. The webinar highlighted how microbiome modulation is opening new avenues for joint health interventions and claim substantiation.

Event Overview:

This session introduced the emerging science behind the gut–joint axis and its implications for joint health innovation. The webinar highlighted how microbiome modulation is opening new avenues for joint health interventions and claim substantiation.

Key Discussion Points

Key Discussion Points

Scientific evidence linking gut health and joint inflammation.

Novel biomarkers and endpoints for gut–joint studies.

Designing clinical trials for probiotics, postbiotics, and synbiotics in joint health.

Translating mechanistic insights into clinically relevant outcomes.

Speakers

Speakers

Anthony L. Almada

Anthony L. Almada

Anthony L. Almada

President and CSO

President and CSO

President and CSO

IMAGINutrition, Inc

IMAGINutrition, Inc

IMAGINutrition, Inc

Anthony L. Almada started working in health/natural foods stores as a teenager in 1975. He performed his undergraduate training (Physiology, minor in Nutritional Biochemistry) at UC Irvine and California State University, Long Beach. He obtained his MSc degree in Nutritional Sciences at UC Berkeley, completing a research thesis on antioxidant and exercise biochemistry. Before and during his graduate training, he engaged in new product innovations, writing, and lecturing for Metagenics, one of the largest direct-to-health-professional dietary supplement brands.

Almada has collaborated on over 95 university and private research clinical trials, ranging from AIDS to body composition changes (from diet and exercise), carbohydrate and lipid metabolism, and zinc metabolism in osteoarthritis. He is the founder of Magnatraction Inc., a think tank focusing on innovation/intellectual properties, clinical research, demand creation, and brand/entity business strategy in the dietary supplement, cosmeceutical, medical food, and food/beverage sectors.

He is the founder or co-founder of several nutrition brands, has sat on several corporate and advisory boards, and has mentored numerous young entrepreneurs and research scientists. Almada has been quoted in The New York Times (front page), Business Week, and Forbes. He was a member of a Research Panel of the Federal Trade Commission’s “Deception in Weight Loss Advertising Workshop,” was an invited presenter at the National Institutes of Health on bringing a dietary supplement to market, and has presented academic and lay seminars on four continents, discussing everything from acne to CBD, functional foods and beverages, and sports performance and banned substances.

Anthony L. Almada started working in health/natural foods stores as a teenager in 1975. He performed his undergraduate training (Physiology, minor in Nutritional Biochemistry) at UC Irvine and California State University, Long Beach. He obtained his MSc degree in Nutritional Sciences at UC Berkeley, completing a research thesis on antioxidant and exercise biochemistry. Before and during his graduate training, he engaged in new product innovations, writing, and lecturing for Metagenics, one of the largest direct-to-health-professional dietary supplement brands.

Almada has collaborated on over 95 university and private research clinical trials, ranging from AIDS to body composition changes (from diet and exercise), carbohydrate and lipid metabolism, and zinc metabolism in osteoarthritis. He is the founder of Magnatraction Inc., a think tank focusing on innovation/intellectual properties, clinical research, demand creation, and brand/entity business strategy in the dietary supplement, cosmeceutical, medical food, and food/beverage sectors.

He is the founder or co-founder of several nutrition brands, has sat on several corporate and advisory boards, and has mentored numerous young entrepreneurs and research scientists. Almada has been quoted in The New York Times (front page), Business Week, and Forbes. He was a member of a Research Panel of the Federal Trade Commission’s “Deception in Weight Loss Advertising Workshop,” was an invited presenter at the National Institutes of Health on bringing a dietary supplement to market, and has presented academic and lay seminars on four continents, discussing everything from acne to CBD, functional foods and beverages, and sports performance and banned substances.

Anthony L. Almada started working in health/natural foods stores as a teenager in 1975. He performed his undergraduate training (Physiology, minor in Nutritional Biochemistry) at UC Irvine and California State University, Long Beach. He obtained his MSc degree in Nutritional Sciences at UC Berkeley, completing a research thesis on antioxidant and exercise biochemistry. Before and during his graduate training, he engaged in new product innovations, writing, and lecturing for Metagenics, one of the largest direct-to-health-professional dietary supplement brands.

Almada has collaborated on over 95 university and private research clinical trials, ranging from AIDS to body composition changes (from diet and exercise), carbohydrate and lipid metabolism, and zinc metabolism in osteoarthritis. He is the founder of Magnatraction Inc., a think tank focusing on innovation/intellectual properties, clinical research, demand creation, and brand/entity business strategy in the dietary supplement, cosmeceutical, medical food, and food/beverage sectors.

He is the founder or co-founder of several nutrition brands, has sat on several corporate and advisory boards, and has mentored numerous young entrepreneurs and research scientists. Almada has been quoted in The New York Times (front page), Business Week, and Forbes. He was a member of a Research Panel of the Federal Trade Commission’s “Deception in Weight Loss Advertising Workshop,” was an invited presenter at the National Institutes of Health on bringing a dietary supplement to market, and has presented academic and lay seminars on four continents, discussing everything from acne to CBD, functional foods and beverages, and sports performance and banned substances.

Dr. Shalini Srivastava

Dr. Shalini Srivastava

Dr. Shalini Srivastava

Associate Director

Associate Director

Associate Director

Vedic Lifesciences

Vedic Lifesciences

Vedic Lifesciences

Shalini Srivastava, MD, has the rare distinction of combining formal training and an early career in mainstream medicine with 10 years of experience in nutraceutical clinical research for CROs and supplement brands. Shalini’s category insights and her ability to traverse the treacherous path of intended marketing claims, clinical trial design, trial conduct, data analysis, and, finally, the approved marketing claims offer immense value to trial sponsors from any regulatory region. As Director of Clinical Development at Vedic Lifesciences, Dr. Srivastava has led the planning and execution of studies for probiotics and botanicals in the gut health and cognition spaces, leading to high-impact publications and award-winning ingredients.

Shalini Srivastava, MD, has the rare distinction of combining formal training and an early career in mainstream medicine with 10 years of experience in nutraceutical clinical research for CROs and supplement brands. Shalini’s category insights and her ability to traverse the treacherous path of intended marketing claims, clinical trial design, trial conduct, data analysis, and, finally, the approved marketing claims offer immense value to trial sponsors from any regulatory region. As Director of Clinical Development at Vedic Lifesciences, Dr. Srivastava has led the planning and execution of studies for probiotics and botanicals in the gut health and cognition spaces, leading to high-impact publications and award-winning ingredients.

Shalini Srivastava, MD, has the rare distinction of combining formal training and an early career in mainstream medicine with 10 years of experience in nutraceutical clinical research for CROs and supplement brands. Shalini’s category insights and her ability to traverse the treacherous path of intended marketing claims, clinical trial design, trial conduct, data analysis, and, finally, the approved marketing claims offer immense value to trial sponsors from any regulatory region. As Director of Clinical Development at Vedic Lifesciences, Dr. Srivastava has led the planning and execution of studies for probiotics and botanicals in the gut health and cognition spaces, leading to high-impact publications and award-winning ingredients.

Vedic Lifesciences — Where Innovation Meets Evidence

Clinical trials, regulatory clarity and brand growth for global health innovators.

Explore Now

Vedic lifesciences scoops Nutra

Ingredients research project award.

connect@vediclifesciences.com

203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053

Want to Join Vedic? Reach our HR

hrd@vediclifesciences.com

© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.

Designed and Developed with ❤️ at Codesis

Vedic Lifesciences — Where Innovation Meets Evidence

Clinical trials, regulatory clarity and brand growth for global health innovators.

Explore Now

Vedic lifesciences scoops Nutra

Ingredients research project award.

connect@vediclifesciences.com

203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053

Want to Join Vedic? Reach our HR

hrd@vediclifesciences.com

© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.

Designed and Developed with ❤️ at Codesis

Vedic Lifesciences — Where Innovation Meets Evidence

Clinical trials, regulatory clarity and brand growth for global health innovators.

Explore Now

Vedic lifesciences scoops Nutra

Ingredients research project award.

Want to Join Vedic? Reach our HR

hrd@vediclifesciences.com

connect@vediclifesciences.com

203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053

Vedic Lifesciences — Where Innovation Meets Evidence

Clinical trials, regulatory clarity and brand growth for global health innovators.

Explore Now

Vedic lifesciences scoops Nutra

Ingredients research project award.

Want to Join Vedic? Reach our HR

hrd@vediclifesciences.com

connect@vediclifesciences.com

203 Morya Landmark 1, Off Link Road, Andheri (W), Mumbai 400053